Explore Health Grants Nationwide

The purpose of this grant is to support the NIH INCLUDE Project by generating integrated genomic and multi-omics data to understand health conditions related to Down syndrome, with the resulting data being shared publicly. Eligible applicants include small businesses, various nonprofit organizations, government entities, educational institutions, and other specified organizations. To apply, interested parties should propose omics assays using existing biospecimens, although no direct funding will be provided under this opportunity.

The grant aims to support research on the protective and pathogenic mechanisms related to mitochondrial function and aging in the context of HIV infection and substance use, with the goal of developing targeted therapies for affected individuals. Eligible applicants include small businesses, various educational institutions, government entities, nonprofits, and other organizations, including those serving specific communities and populations. Application details are not provided in the description; for further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

The grant aims to promote research on the protective and pathogenic mechanisms related to mitochondrial function and aging in the context of HIV infection and substance use, with the goal of developing targeted therapies to improve outcomes for aging individuals with HIV and addiction. Eligible applicants include independent school districts, public and private higher education institutions, various levels of government, nonprofits, small businesses, and other organizations, including those serving specific communities such as Native Americans and historically underrepresented groups. Application details are not provided in the description; interested parties should refer to the full opportunity announcement for more information.

The grant aims to fund studies on the etiology and pathogenesis of type 1 diabetes, utilizing data and samples from clinical trials to enhance understanding and prevention of the disease. Eligible applicants include various government entities, educational institutions, nonprofits, for-profit organizations, and other specified groups such as tribal organizations and historically black colleges. Application details can be found in the full opportunity announcement, and inquiries can be directed to the NIH Grants Information at grantsinfo@nih.gov.

The International Research Scientist Development Award (IRSDA) aims to support advanced postdoctoral U.S. research scientists and recently-appointed U.S. junior faculty for a mentored research career development experience in low- or middle-income countries, focusing on global health. Eligible applicants include postdoctoral research scientists and junior faculty from any health-related discipline who are at least two years post-doctorate. Application details are not specified in the provided text; interested individuals should refer to the full opportunity announcement for further instructions.

The New Investigator Gateway Award in T1D Research aims to support innovative projects and new investigators in Type 1 Diabetes research by embedding them within established collaborative research networks. Eligible applicants include public and private entities such as government agencies, small businesses, nonprofits, and educational institutions. Application details are not specified in the provided text; for further information, applicants should refer to the full opportunity announcement or contact NIH Grants Information.

The grant aims to support multi-center clinical trials focused on neurological emergencies, facilitating collaboration within the NIH SIREN Network for efficient trial implementation and data management. Eligible applicants include various government entities, nonprofits, businesses, and educational institutions, as well as specific organizations like Native American tribal governments and historically black colleges. Application details are not specified in the provided text, but interested parties can contact NIH Grants Information for further inquiries.

The purpose of this grant is to accelerate the establishment of effective biomarkers for Alzheimer's disease and related dementias, supporting their analytical and clinical validation in line with FDA standards. Eligible applicants include various government entities, for-profit and nonprofit organizations, educational institutions, and other specific groups such as tribal governments and historically black colleges. Application details are not specified, but interested parties can contact NIH Grants Information for further inquiries.

The purpose of this grant is to support the preparation of book-length manuscripts and other works that are significant to U.S. health professionals, public health officials, biomedical researchers, and historians of health sciences. Eligible applicants include for-profit organizations, nonprofits, government entities, educational institutions, and various other organizations, including those serving Native American populations. To apply, interested parties should refer to the full opportunity announcement for detailed instructions and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.

The purpose of this grant is to establish a drug development infrastructure aimed at enhancing the substance use disorder (SUD) drug development pipeline by supporting the evaluation and validation of repurposed and repositioned drugs. Eligible applicants include independent school districts, higher education institutions, state and local governments, nonprofits, and for-profit organizations, among others. To apply, interested parties should refer to the full opportunity announcement for detailed application procedures and contact NIH Grants Information for inquiries.

The Drug-Free Communities (DFC) Support Program aims to prevent and reduce opioid and methamphetamine use, as well as prescription drug misuse among youth aged 12-18 in U.S. communities. Eligible applicants include nonprofit organizations, public and private educational institutions, and government entities that are current or former DFC Support Program recipients and can demonstrate higher-than-average rates of substance misuse. To apply, interested organizations should contact Christi Jones at CARA_NOFO@cdc.gov for further information.

The grant aims to support the development and implementation of a Clinical Coordinating Center (CCC) for multi-site clinical trials relevant to the NHLBI's research mission. Eligible applicants include small businesses, various government entities, educational institutions, and nonprofits, among others. To apply, applicants must submit both a CCC application and a collaborating Data Coordinating Center (DCC) application by the same due date and are encouraged to contact the appropriate Scientific/Research contact prior to submission.